← Leaderboards
Chin Hur
Massachusetts General Hospital
$15,301,977
Attributed
$31,327,332
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,327,332 · 12
By mechanism
U01$17,121,814 · 4
R01$9,954,616 · 4
U24$3,140,717 · 1
K07$700,650 · 1
R21$399,535 · 1
R13$10,000 · 1
Top collaborators
- John Matthew Inadomi15 shared
- Georg E Luebeck15 shared
- Fay Kastrinos7 shared
- Chung Yin Kong6 shared
- Kenneth K Wang5 shared
- Jennifer M. Yeh5 shared
- Jeanine M. Genkinger4 shared
- Jianhua Hu4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Nabeel Bardeesy$18,920,034
- April Jorge$1,039,800
- Christine S Ritchie$16,346,545
- Carrie Elizabeth Cunningham$4,319,121
- Ryan Bruce Corcoran$7,598,235
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsModels And SimulationMorbidity - Disease RateIncidenceScreeningMortalityCancer ControlFutureRisk FactorsEsophageal AdenocarcinomaResearch PersonnelBurden Of IllnessCollaborationsBarrett EsophagusBaseCost EffectivenessInnovationPreventionResourcesPremalignantAreaNatural HistoryFoundationsMission
Grant awards (60)
Comparative modeling of gastric cancer health drivers and prevention in the US and globally$899,170
U01 · FY2025 · CA · contact PI
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers$847,919
U24 · FY2025 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$372,279
R01 · FY2025 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$70,872
R01 · FY2025 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$615,728
U01 · FY2024 · CA · contact PI
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers$597,793
U24 · FY2024 · CA · contact PI
A Personalized Approach to Targeted Esophageal Cancer Screening$488,626
R01 · FY2024 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$353,665
R01 · FY2024 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$70,872
R01 · FY2024 · CA · contact PI
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers$830,961
U24 · FY2023 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$810,184
U01 · FY2023 · CA · contact PI
A Personalized Approach to Targeted Esophageal Cancer Screening$507,813
R01 · FY2023 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$364,833
R01 · FY2023 · CA · contact PI
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers$864,044
U24 · FY2022 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$810,695
U01 · FY2022 · CA · contact PI
A Personalized Approach to Targeted Esophageal Cancer Screening$489,169
R01 · FY2022 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$366,520
R01 · FY2022 · CA · contact PI
Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer$222,661
R21 · FY2022 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$919,195
U01 · FY2021 · CA · contact PI
A Personalized Approach to Targeted Esophageal Cancer Screening$506,684
R01 · FY2021 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$391,146
R01 · FY2021 · CA · contact PI
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype$384,740
R01 · FY2021 · CA · contact PI
Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer$176,874
R21 · FY2021 · CA · contact PI
A Personalized Approach to Targeted Esophageal Cancer Screening$469,359
R01 · FY2020 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$460,388
R01 · FY2020 · CA · contact PI
Controlling Esophageal Cancer: A Collaborative Modeling Approach$1,163,113
U01 · FY2019 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$381,565
R01 · FY2019 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$69,242
R01 · FY2019 · CA · contact PI
Controlling Esophageal Cancer: A Collaborative Modeling Approach$1,173,755
U01 · FY2018 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$419,924
R01 · FY2018 · CA · contact PI
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment$306,765
R01 · FY2018 · CA · contact PI
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment$86,744
R01 · FY2018 · CA · contact PI
Controlling Esophageal Cancer: A Collaborative Modeling Approach$1,162,462
U01 · FY2017 · CA · contact PI
Esophageal Cancer from Cells to Population: A Multiscale Approach$617,479
U01 · FY2017 · CA
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment$407,924
R01 · FY2017 · CA · contact PI
Optimizing the Treatment of Pancreatic Adenocarcinoma$398,519
R01 · FY2017 · CA · contact PI
Controlling Esophageal Cancer: A Collaborative Modeling Approach$1,171,793
U01 · FY2016 · CA · contact PI
Esophageal Cancer from Cells to Population: A Multiscale Approach$630,302
U01 · FY2016 · CA
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment$426,391
R01 · FY2016 · CA · contact PI
Controlling Esophageal Cancer: A Collaborative Modeling Approach$1,186,904
U01 · FY2015 · CA · contact PI
Esophageal Cancer from Cells to Population: A Multiscale Approach$665,400
U01 · FY2015 · CA
Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment$400,332
R01 · FY2015 · CA · contact PI
Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project$728,117
U01 · FY2014 · CA · contact PI
Esophageal Cancer from Cells to Population: A Multiscale Approach$648,084
U01 · FY2014 · CA
Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening$345,570
R01 · FY2014 · CA · contact PI
Esophageal Cancer from Cells to Population: A Multiscale Approach$721,478
U01 · FY2013 · CA
Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project$719,202
U01 · FY2013 · CA · contact PI
Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening$334,885
R01 · FY2013 · CA · contact PI
Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project$780,703
U01 · FY2012 · CA · contact PI
Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening$356,257
R01 · FY2012 · CA · contact PI
Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project$829,022
U01 · FY2011 · CA · contact PI
Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening$356,257
R01 · FY2011 · CA · contact PI
Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project$869,028
U01 · FY2010 · CA · contact PI
Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening$367,275
R01 · FY2010 · CA · contact PI
The Prevention of Esophageal Adenocarcinoma$141,750
K07 · FY2009 · CA · contact PI
The Prevention of Esophageal Adenocarcinoma$140,940
K07 · FY2008 · CA · contact PI
The Prevention of Esophageal Adenocarcinoma$140,130
K07 · FY2007 · CA · contact PI
Advancing an Evidence-Based Approach to Barrett's Esophagus: A Health Outcomes Re$10,000
R13 · FY2007 · DK · contact PI
The Prevention of Esophageal Adenocarcinoma$139,320
K07 · FY2006 · CA · contact PI
The Prevention of Esophageal Adenocarcinoma$138,510
K07 · FY2005 · CA